Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-03-25 | Charles J. Dockendorff Independent Director Former Executive Vice President and Chief Financial Officer of Covidien plc Director Since: April 2015 Age: 65 Committees: Audit (Chair, Financial Expert); Finance Other Public Company Boards: Haemonetics Corporation; Hologic, Inc.; Keysight Technologies, Inc. Education: University of Massachusetts at Amherst, B.B.A. in Accounting; Bentley College, M.S. in Finance |
| 2021-03-24 | Charles J. Dockendorff Independent Director Former Executive Vice President and Chief Financial Officer of Covidien plc Director Since: April 2015 Age: 66 Committees: Audit (Chair, Financial Expert); Risk Other Public Company Boards: Haemonetics Corporation; Hologic, Inc.; Keysight Technologies, Inc. Education: University of Massachusetts at Amherst, B.B.A. in Accounting; Bentley College, M.S. in Finance |
| 2022-03-23 | Charles J. Dockendorff, Independent Age: 67 Former Executive Vice President and Chief Financial Officer of Covidien plc DIRECTOR SINCE: April 2015 BOARD COMMITTEES: Audit (Chair, Financial Expert); Risk OTHER CURRENT PUBLIC BOARDS: Haemonetics Corporation; Hologic, Inc.; Keysight Technologies, Inc. |
| 2023-03-22 | Charles J. DockendorffIndependent Age:68 Former Executive Vice President and Chief Financial Officer of Covidien plc Director since: April 2015 Board Committees: Audit(Chair, Financial Expert); Risk |
| 2024-03-20 | Charles J. Dockendorff Independent Age: 69 Board Committees: Audit (Financial Expert) Risk Director Compensation Table Charles J. Dockendorff 121,250 Fees Earned or Paid in Cash 205,000 Stock Awards 326,250 Total |
| Filing Date | Source Excerpt |
|---|---|
| 2014-06-13 | Mr. Dockendorff, 59, is currently Executive Vice President and Chief Financial Officer (CFO) of Covidien plc, a leading $10 billion global healthcare products company. |
| 2015-06-11 | Mr. Dockendorff, 60, joined the Board of Directors in 2014 and is Chairman of the Audit Committee. |
| 2016-06-10 | Mr. Dockendorff, 61, joined the Board of Directors in 2014 and is Chairman of the Audit Committee. |
| 2017-06-12 | Charles J. Dockendorff, 62, joined the Board of Directors in 2014 and is Chairman of the Audit Committee. He currently serves as a member of the Board of Directors of Boston Scientific Corporation, where he is currently Chairman of the Audit Committee and member of the Finance Committee, Hologic, Inc., where he serves as a member of the Audit Committee, and Keysight Technologies Inc., where he is Chairman of the Audit and Finance Committee and a member of the Nominating and Corporate Governance Committee. Compensation for the Board of Directors in fiscal 2017 was $258,477 for Mr. Dockendorff. |
| 2018-06-12 | Charles J. Dockendorff Retired Executive Vice President and Chief Financial Officer, Covidien plc Age: 63 Mr. Dockendorff joined our Board in 2014 and is Chairman of the Audit Committee. DIRECTOR COMPENSATION TABLE FOR FISCAL YEAR ENDED MARCH 31, 2018 Charles J. Dockendorff Fees Earned or Paid in Cash ($): 97,000 Stock Awards ($): 170,000 Total ($): 267,000 |
| 2019-06-12 | Charles J. Dockendorff Retired Executive Vice President and Chief Financial Officer, Covidien plc. Age: 64. Mr. Dockendorff joined our Board in 2014 and is Chair of the Audit Committee and a member of the Governance and Compliance Committee. Director Compensation Table for Fiscal Year Ended March 30, 2019 shows total compensation of $266,939. |
| 2020-06-08 | Charles J. Dockendorff Retired Executive Vice President and Chief Financial Officer, Covidien plc Age: 65 Mr. Dockendorff joined our Board in 2014 and is Chair of the Audit Committee and a member of the Governance and Compliance Committee. Mr. Dockendorff served as Executive Vice President and Chief Financial Officer of Covidien plc, a global healthcare company, and its predecessor, Tyco Healthcare, from 1995 until his retirement in 2015. Mr. Dockendorff joined the Kendall Healthcare Products Company, the foundation of the Tyco Healthcare business, in 1989 as Controller and was named Vice President and Controller five years later. Prior to joining Kendall/Tyco Healthcare, Mr. Dockendorff was the Chief Financial Officer, Vice President of Finance and Treasurer of Epsco, Inc. and Infrared Industries, Inc. Earlier in his career, Mr. Dockendorff worked as an accountant for Arthur Young & Company (now Ernst & Young LLP) and the General Motors Corporation. |
| 2021-06-17 | Mr. Dockendorff joined our Board in 2014 and is Chair of the Audit Committee and a member of the Governance and Compliance Committee. Mr. Dockendorff served as Executive Vice President and Chief Financial Officer of Covidien plc, a global healthcare company, and its predecessor, Tyco Healthcare, from 1995 until his retirement in 2015. Mr. Dockendorff joined the Kendall Healthcare Products Company, the foundation of the Tyco Healthcare business, in 1989 as Controller and was named Vice President and Controller five years later. Prior to joining Kendall/Tyco Healthcare, Mr. Dockendorff was the Chief Financial Officer, Vice President of Finance and Treasurer of Epsco, Inc. and Infrared Industries, Inc. Earlier in his career, Mr. Dockendorff worked as an accountant for Arthur Young & Company (now Ernst & Young LLP) and the General Motors Corporation. |
| 2022-06-17 | Charles J. Dockendorff Retired Executive Vice President and Chief Financial Officer, Covidien plc Age: 67 Mr. Dockendorff joined our Board in July 2014 and is Chair of the Audit Committee and a member of the Governance and Compliance Committee. Mr. Dockendorff served as Executive Vice President and Chief Financial Officer of Covidien plc, a global healthcare company, and its predecessor, Tyco Healthcare, from 1995 until his retirement in 2015. Mr. Dockendorff joined the Kendall Healthcare Products Company, the foundation of the Tyco Healthcare business, in 1989 as Controller and was named Vice President and Controller five years later. Prior to joining Kendall/Tyco Healthcare, Mr. Dockendorff was the Chief Financial Officer, Vice President of Finance and Treasurer of Epsco, Inc. and Infrared Industries, Inc. Earlier in his career, Mr. Dockendorff worked as an accountant for Arthur Young & Company (now Ernst & Young LLP) and the General Motors Corporation. |
| 2023-06-16 | Charles J. Dockendorff Retired Executive Vice President and Chief Financial Officer, Covidien plc Age: 68 Mr. Dockendorff joined our Board in July 2014 and is Chair of the Audit Committee and a member of the Governance and Compliance Committee. Director Compensation Table for Fiscal Year Ended April 1, 2023 Charles J. Dockendorff Fees Earned or Paid in Cash: $103,000 Stock Awards: $189,953 Total: $292,953 |
| 2024-06-07 | Retired Executive Vice President and Chief Financial Officer, Covidien plc |
| Filing Date | Source Excerpt |
|---|---|
| 2018-01-26 | Mr. Dockendorff was appointed to our Board in 2017. He was formerly Executive Vice President and Chief Financial Officer of Covidien plc. The Audit and Finance Committee is responsible for assisting our Board in the oversight of our financial reporting process. The Board appointed Mr. Dockendorff as chair of the Audit and Finance Committee. The following table sets forth the compensation paid to our non-employee directors for service on our Board during the fiscal year ended September 30, 2017. |
| 2019-01-18 | Charles J. Dockendorff Former Chief Financial Officer and Executive Vice President Covidien plc Age: 64 Director Since: 2017 Committees: Audit and Finance (Chair) 2018 Director Compensation Table: Total $273,987 |
| 2020-01-22 | Charles J. Dockendorff • Independent Former Chief Financial Officer and Executive Vice President, Covidien plc. Age 65, Director Since 2017. Committees: Audit and Finance (Chair). 2019 Director Compensation Table: Total $299,359. |
| 2021-01-21 | Charles J. Dockendorff (Independent) Former Chief Financial Officer and Executive Vice President Covidien plc Age 66 Director Since 2017 Committees: Audit and Finance (Chair). Compensation: $299,682. |
| 2022-01-20 | Charles J. Dockendorff (Independent) Former Chief Financial Officer and Executive Vice President Covidien plc Age 67 Director Since 2017 Committees • Audit and Finance (Chair) 2021 Director Compensation Table Charles J. Dockendorff Fees Earned or Paid in Cash ($) 124,688 Stock Awards ($) 104,982 Option Awards ($) 104,992 Total ($) 334,662 |
| 2023-01-19 | Charles J. Dockendorff (Independent) Former Chief Financial Officer and Executive Vice President Covidien plc Age 68 Director Since 2017 Committees • Audit and Finance (Chair) 2022 Director Compensation Table: Fees Earned or Paid in Cash $115,000 Stock Awards $109,988 Option Awards $109,989 Total $334,977 |
| 2024-01-18 | Charles J. Dockendorff (Independent) Former Chief Financial Officer and Executive Vice President Covidien plc Age 69 Director Since 2017 Audit and Finance (CHAIR) 2023 Director Compensation Table: Fees Earned or Paid in Cash $115,000, Stock Awards $114,988, Option Awards $114,975, Total $344,963 |
| 2025-01-16 | Charles J. Dockendorff (Independent) Former Chief Financial Officer and Executive Vice President Covidien plc. Age 70, Director Since 2017. Committees: Audit and Finance (Chair). 2024 Director Compensation Table shows total compensation of $354,952. |
Data sourced from SEC filings. Last updated: 2026-02-03